---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-040975"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:47:35.666839+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Sanuwave receives $5M cash from option exercise for patent sale

## Summary
- Licensee exercised option on August 21, 2025, to acquire patents for intravascular shockwave applications.
- Sanuwave received a $5.0M cash payment in connection with the option exercise.
- Previously, the Licensee paid $2.5M for an exclusive license and the option in March 2024.
- The patents are related to the field of intravascular shockwave applications.
- No additional ongoing obligations from Sanuwave are disclosed.

## SEC filing metadata
- accession: 0001628280-25-040975
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025040975/0001628280-25-040975-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025040975/snwv-20250821.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-040975
- JSON: https://secwatch.observer/filing/0001628280-25-040975.json
- Plain text: https://secwatch.observer/filing/0001628280-25-040975.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.